Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

evaluated newly approved RSV vaccines: Arexvy, manufactured by GSK, and Abrysvo, manufactured by Pfizer. The study did not include a third approved vaccine, Moderna's mRESVIA. The vaccines are now ...

Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...

Vaccination against respiratory syncytial virus ... the societal cost per QALY saved was $196,842 for GSK's Arexvy and $176,557 for Pfizer's Abrysvo. For adults aged 65 and older, the cost was ...

Sept 3 (Reuters) - Vaxcyte's (PCVX.O), opens new tab shares surged as much as 48% to a record high on Tuesday after the company said its experimental pneumococcal vaccine showed promising results ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...

The world’s first respiratory syncytial virus (RSV) vaccine for older adults, Arexvy, is registered for use in Canada, Australia, the US, the UK, the European Union, Japan and New Zealand.

Officials hope to vaccinate more than 640,000 children under age 10. A mass polio vaccination campaign is underway in Gaza to inoculate children after the first case in 25 years was recently ...

However, in a statement late Saturday, the office of Israeli Prime Minister Benjamin Netanyahu said that "reports of a general cease-fire for the purpose of giving polio vaccines in Gaza are false." ...

Depending on the production capacity of manufacturers, agreements for up to 12 million doses through 2025 can be made, according to the statement. The United Nations Children's Fund (UNICEF) has ...

Israel and Hamas agreed to pause the war to permit the vaccination of 640,000 children in Gaza, a daunting effort for health workers. By Bilal Shbair Erika Solomon and Hiba Yazbek Bilar Shbair ...